Dr.ssa Valentina Rinaldi

Chi Sono

Laurea presso la facoltà di Medicina Veterinaria di Napoli (2009).

Esperienze lavorative

2009-2014: Istituto Nazionale Tumori IRCCS “G.Pascale” (NA), ricercatrice.

2012-2014: Centro Oncologico Veterinario (BO), collaboratrice e ricercatrice.

2014-2015: Ospedale Veterinario “I Portoni Rossi”, collaboratrice e co-fondatrice del reparto di oncologia medica veterinaria.

2016-2018: Clinica Veterinaria “Città di Carpi” (MO), collaboratrice.

2018-oggi: Clinica Veterinaria Jenner (PR), collaboratrice, responsabile del servizio di oncologia medica.

Formazione

Ha partecipato a svariati seminari, congressi, simposi e corsi di formazione inerenti l’oncologia e la farmacologia.

Pubblicazioni in letteratura – Comunicazioni brevi – Casi clinici

Assessment of bone marrow infiltration diagnosed by flow cytometry in canine large B cell lymphoma: Prognostic significance and propo- sal of a cut-off value” [Co-autrice – Vet J. 2013-06-1].

Comparison of the binding and internalization properties of 12 DOTA-coupled and (111)In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607” [Co-autrice – Eur J Nucl Med Mol Imaging 2011].

Non-invasive ripetitive imaging of somatostatin receptor 2 gene transfer with positron emission tomography” [Co-autrice – Human Gene Theraphy 2010].

Comunicazioni a congressi:

Comparison of the binding and internalization properties of 12 DOTA-coupled and 111In- labelled CCK2/Gastrin receptor binding peptides: a collaborative project under COST Action BM0607” [Co-autrice – Nuclear Medicine & Molecular Imaging, Wien, Austria October 2010].

Monitoring AAV mediated gene transfer with Ga-68 DOTATATE by PET” [Co-autrice – Nuclear Medicine & Molecular Imaging, Wien, Austria, October 2010].

PET Imaging of AVV-MEDIATED GENE TRANSFER TO LIVER AND MUSCLE” [Co-autrice – 4th European Molecular Imaging Meeting, Barcelona, Spain May 27 to May 30,2009].

Comparision of serum stability and cellular binding properties of 8-DOTA-coupled- Bombesin receptor targeting peptides” [Co-autrice – European Journal of Nuclear Medicine & Molecular Imaging, Milan, October 2012].

Monitoring AAV mediated somatostatin receptor gene transfer by PET with Ga68- DOTATATE” [Co-autrice – Nuclear Medicine and Biology 2010].

Ga-68 DOTA-Nle-Asp-DPhe-Alpha-MSH(4-11)Amide (Napamide) PET For Melanocortin 1 Receptor Targeting In Melanoma” [Co-autrice – European Journal of Nuclear Medicine & Molecular Imaging, Barcelona, Spain 2009].

Non-invasive in vivo imaging of somatostatin receptor 2 gene transfer with positro emission tomography” [Co-autrice – European Society of Gene & Cell Therapy, 2008].

Valutazione in vivo e in vitro del Ga68 DOTA-Nle-Asp-DPhe-aMSH(4-11)amide (NAPAMI- DE) per il recettore 1 della melanocortina come target tumorale del melanoma”[Co-autrice – Giornate Scientifiche Facoltà di Agraria, 10,11 e 12 Dicembre 2008].

The Human Somatostatin 2 Receptor for Ga-68-DOTATATE Reporter Gene Imaging” [Co-autrice – European Journal of Nuclear Medicine & Molecular Imaging, Munich, October 2008].

In vitro Evaluation of Ga68 DOTA-Nle-Asp-DPhe-αMSH(4-11)amide (NAPAMIDE) for Me- lanocortin 1 Receptor Targeting in Melanoma” [Co-autrice – European Journal of Nuclear Medicine & Molecular Imaging, Munich, October 2008].